According to a fresh study.

They state the results suggest that acupuncture may complement traditional infertility treatments and help men reach their complete reproductive potential. Related StoriesFEC recognizes Rachel S. Weinerman for getting 2015 Scientific System Prize Paper AwardChanges in cellular metabolites regulate earliest stages of embryonic stem cell developmentStandard clomiphene treatment better than proposed alternate for unexplained fertilityAn estimated 10 percent of guys are infertile, and the male partner is one factor in up to 50 percent of infertile couples, write the researchers. In many cases, the reason for male infertility is unfamiliar. Previous studies of acupuncture and male infertility have got suggested that acupuncture can improve sperm creation and motility .Green, M.D., F.R.C.P., Andrew J. Wardlaw, Ph.D., F.R.C.P., and Ian D. Pavord, D.M., F.R.C.P.: Exacerbations and Mepolizumab of Refractory Eosinophilic Asthma Asthma is a complex chronic inflammatory disorder of the bronchial tree. Exacerbations are connected with substantial mortality and morbidity and with considerable healthcare costs.1 Exacerbations differ from day-to-day symptoms in that they respond poorly to usual inhaled therapy and so are more closely associated with increased airway inflammation.2 The link to eosinophilic airway inflammation may be particularly important, since infiltration of the airway mucosa with activated eosinophils is seen in postmortem examinations of individuals who have passed away of acute severe asthma,3 and markers of eosinophilic airway inflammation increase prior to the onset of exacerbations that are induced by the withdrawal of corticosteroid treatment.4,5 Moreover, management strategies that control eosinophilic airway inflammation along with the scientific manifestations of asthma are connected with a reduction in the frequency of exacerbations.6,7 A scholarly research of asthma therapy involving mepolizumab, a humanized monoclonal antibody against interleukin-5, offers the prospect of clarifying the part of eosinophils in exacerbations, since mepolizumab is a selective and effective inhibitor of eosinophilic irritation.8-11 Results of clinical trials of the agent among people with asthma have been disappointing,9,11 although these studies have got focused on outcome measures that are not closely connected with eosinophilic airway inflammation and have included populations that were selected based on clinical and physiological characteristics rather than the presence of eosinophilic airway swelling.12 We tested the hypothesis that eosinophils are important in the pathogenesis of asthma exacerbations by studying the effect of treatment with mepolizumab for 12 months on the frequency of exacerbations among subjects who had refractory asthma and proof eosinophilic airway inflammation despite treatment with high doses of corticosteroids.